Results 201 to 210 of about 41,061 (224)

Linezolid resistance seen

British Journal of Infection Control, 2001
openaire   +1 more source

Update on linezolid resistance in staphylococci

2012
Linezolid is the only oxazolidinone antibiotic approved for clinical use. It inhibits bacterial protein synthesis by an original mechanism blocking the initiation phase, at a very early stage. It binds to the ribosome at the domain V of 23S rRNA and prevents transfer of amino acid on tRNA from A-site to P-site. Linezolid resistance was reported quickly
Bourgeois-Nicolaos, N., Rouard, C., Desroches, M., Doucet-Populaire, F.   +3 more
openaire   +2 more sources

Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment

European Journal of Clinical Microbiology & Infectious Diseases, 2006
M G, Bonora, M, Ligozzi, A, Luzzani, M, Solbiati, E, Stepan, R, Fontana   +5 more
openaire   +2 more sources

9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea

Lancet, The, 2022
exaly  

Linezolid resistance in a clinical isolate of Staphylococcus aureus

Lancet, The, 2001
Sotirios Tsiodras
exaly  

Linezolid for multidrug-resistant tuberculosis – Authors' reply

The Lancet Infectious Diseases, 2013
Kwok-Chiu, Chang, Chi-Chiu, Leung, Charles L, Daley   +2 more
openaire   +2 more sources

Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis

New England Journal of Medicine, 2012
Hongjo Choi, Laura E Via, Ray Y Chen
exaly  

Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms

Drug Resistance Updates, 2014
Lalitagauri M Deshpande, Ronald N Jones
exaly  

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature

Drug Resistance Updates, 2018
Jennifer K Bender, Vincent Cattoir, Kristin Hegstad   +2 more
exaly  

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis

EBioMedicine, 2015
Yumi Park, Véronique A Dartois, Laura E Via   +2 more
exaly